Shore Capital is delighted to have acted as Nominated Adviser and Sole Bookrunner to Light Science Technologies on its £6.6m fundraise to fund the acquisition of RLUK Injection Ltd (including its wholly owned subsidiary Injectaclad Ltd), the remaining 10% minority interest in UK Circuits and Electronics Solutions Limited, together with a related property asset, for a total consideration of up to c.£5.4 million.  The fundraise consisted of a £6m Placing and £0.6m retail offer. The Placing was supported by both existing and new institutional investors.

The Company’s PFP division is already an installer of Injectaclad, and the acquisition of RLUK Injection will secure the intellectual property and supply chain for this critical product, enabling LSTH to capture a greater share of the value chain and accelerate the growth of the PFP division. The acquisition is expected to enhance the Group’s reputation as an industry leader in passive fire protection and open up new opportunities for expansion in the UK and potentially internationally. The UK Circuits Acquisition will consolidate the Company’s ownership of this important division, providing full control over strategic decision-making and operational management.

Light Science Technologies Holdings plc is an innovative technology and manufacturing business delivering practical solutions to global challenges, including food security and fire safety.

Shore Capital team

• Corporate Advisory: Stephane Auton, George Payne
• Sales champion: Maisie Rose Brown
• Research: Robert Sanders
• Trading: Simon Schaffer and David Simmons
• Investor Relations: Lisa Mason